The UK's National Health Service will now allow patients to receive NHS care even if they privately pay for drugs, and will implement measures to increase access to NHS-covered treatments.
Alan Johnson, the UK's health secretary, overturned a rule that had previously banned patients from receiving services if they paid for their own medications. At the same time, Michael Richards, the National Cancer Director, published a report that showed government plans to work on new pricing arrangements for new drugs as well as speed up the appraisal and approval process for new medications.
As a result, the public will have greater access to drugs for cancer and other terminal conditions. The move ends what some have called a "cruel practice" that prevented individuals from purchasing certain medications by removing other NHS benefits.
- see the full story [1] at the Financial Times
Related Articles:
Costly cancer meds put NHS in quandary [3]
Tories propose NICE approval reforms [4]
UK politicians: Pay for drug performance [5]
Does NICE want pricing power? [6]
U.K. drug deal cuts prices 5% [7]
Links:
[1] http://www.ft.com/cms/s/0/5e1c79ce-aa81-11dd-897c-000077b07658.html?nclick_check=1
[2] http://www.firstwordplus.com/Fws.do?articleid=BED9424ED663494A85CA04B9DB8DB0FD
[3] http://www.fiercepharma.com/story/costly-cancer-meds-put-nhs-quandary/2008-06-24
[4] http://www.fiercepharma.com/story/tories-propose-nice-approval-reforms/2008-11-03
[5] http://www.fiercepharma.com/story/u-k-politicians-pay-drug-performance/2008-09-11
[6] http://www.fiercepharma.com/story/does-nice-want-pricing-power/2008-08-26
[7] http://www.fiercepharma.com/story/u-k-drug-deal-cuts-prices-5/2008-06-19